HCA Healthcare, Inc. $HCA Stock Holdings Trimmed by University of Texas Texas AM Investment Management Co.

University of Texas Texas AM Investment Management Co. lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 97.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 338 shares of the company’s stock after selling 14,189 shares during the period. University of Texas Texas AM Investment Management Co.’s holdings in HCA Healthcare were worth $144,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in HCA. Sunbelt Securities Inc. boosted its holdings in shares of HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after acquiring an additional 3,945 shares during the period. Sei Investments Co. increased its holdings in shares of HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock valued at $221,380,000 after acquiring an additional 100,764 shares during the period. SEB Asset Management AB purchased a new stake in HCA Healthcare in the 1st quarter valued at $75,534,000. Darsana Capital Partners LP raised its position in HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares during the last quarter. Finally, Bank of America Corp DE acquired a new stake in HCA Healthcare during the 2nd quarter worth $238,457,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Michael J. Schlosser sold 1,200 shares of the stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total value of $593,580.00. Following the completion of the transaction, the executive vice president owned 1,443 shares in the company, valued at $713,779.95. This trade represents a 45.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Jon Foster sold 21,713 shares of the firm’s stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the sale, the chief operating officer owned 10,000 shares of the company’s stock, valued at $4,949,500. This trade represents a 68.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 32,913 shares of company stock worth $16,481,129. Corporate insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on HCA. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research note on Monday, July 27th. Mizuho set a $495.00 target price on shares of HCA Healthcare in a research note on Wednesday, October 28th. Robert W. Baird raised their price target on HCA Healthcare from $393.00 to $409.00 and gave the stock a “neutral” rating in a report on Wednesday, October 28th. Royal Bank Of Canada boosted their price target on HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a research report on Friday, October 30th. Finally, Oppenheimer decreased their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $480.13.

HCA Healthcare Stock Performance

Shares of HCA opened at $504.85 on Tuesday. The stock has a market capitalization of $105.46 billion, a P/E ratio of 17.04, a P/E/G ratio of 1.71 and a beta of 1.11. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The company’s fifty day moving average is $445.41 and its two-hundred day moving average is $445.45.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The company had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. During the same quarter last year, the business earned $6.96 EPS. The business’s revenue was up 3.6% on a year-over-year basis. Sell-side analysts predict that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s payout ratio is presently 10.34%.

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.